✦ LIBER ✦

Applications for oncologic drugs — Lessons from the oncologic drug advisory committee

✍ Scribed by I. Amanam; T. Kiet; N. Young-Lin; L. Chen; R. Brooks; S. Ueda; B. Monk; D. Kapp; D. Hoth; J. Chan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trends and progress of oncology drug dev

✍ I. Amanam; T. Kiet; N. Young-Lin; L. Chen; R. Brooks; S. Ueda; B. Monk; D. Kapp; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Mechanisms of Drug Resistance in Epileps

✍ Devin K Binder 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 24 KB

Irinotecan/5-Fluorouracil/Leucovorin in

✍ Maxine Fisher; Edward Chu 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB

The challenges of new drugs benefits and

✍ Pol F. Boudes 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Multi-species toxicology approaches for

✍ Joseph E. Tomaszewski 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Specificity of the phase I trial for cyt

✍ JP Armand; M. Klink-Alakl; G. Recondo; M. de Forni 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB